2. Signaling Pathways
  3. Metabolic Enzyme/Protease
  4. Glycosidase

Glycosidase

Glycosidase

Glycosidase

Related Products

PDF 0.94 MB

Glycosidase are a class of enzymes which catalyze the hydrolysis of glycosidic bonds. In living organisms, Glycosidase are involved in carbohydrate metabolism. They can degrade polysaccharides such as starch and glycogen into monosaccharides, providing energy for cells. Glycosidase also participate in the synthesis and modification of biological macromolecules such as glycoproteins and glycolipids, playing a crucial role in cell recognition and signal transduction. Additionally, in plants and microorganisms, Glycosidase are involved in the metabolism of cell wall polysaccharide components, affecting cell growth, differentiation, and morphogenesis. Gene mutations of Glycosidase can trigger genetic diseases, leading to abnormal metabolism in the body and damage to organ functions. Changes in their activity are associated with various diseases such as diabetes, infectious diseases, and tumors, and can influence the occurrence and development of diseases[1][2].

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N17777
    Cyclocarin A
    		Inhibitor
    Cyclocarin A is a triterpenoid compound that can be isolated from the leaves of Cyclocarya paliurus. Cyclocarin A shows only weak inhibitory activity against α-glucosidase, lipase, DPP-IV, aldose reductase, and human cancer cell lines (IC50>10 μM).
    Cyclocarin A
  • HY-14829F
    L-Afegostat
    		Inhibitor
    L-Afegostat (5-epi-Isofagomine) is a glycosidase inhibitor. L-Afegostat is an iminosugar that can be used for the synthesis of carbohydrates. L-Afegostat shows enzyme inhibition to β-Glucosidase with an Ki of 30 μM.
    L-Afegostat
  • HY-163005
    α-Glucosidase-IN-43
    		Inhibitor
    α-Glucosidase-IN-43 (compound AS14) is an α-glucosidase inhibitor (IC50: 4.32 μM) with acute hypoglycemic activity. α-Glucosidase-IN-43 exhibits safety and in vivo efficacy, is nontoxic to normal mouse fibroblasts, and is able to rescue streptozotocin (HY-13753)-induced diabetic rats. α-Glucosidase-IN-43 can be used to study postprandial hyperglycemia in diabetic patients.
    α-Glucosidase-IN-43
  • HY-N17857
    Quercetin 3'-methoxy-3-O-α-L-arabinofuranoside
    		Inhibitor
    Quercetin 3'-methoxy-3-O-α-L-arabinofuranoside is a weak inhibitor of α-glucosidase, which can found in the leaves and twigs of Fagus hayatae.
    Quercetin 3'-methoxy-3-O-α-L-arabinofuranoside
  • HY-E70116A
    Isoamylase, Pseudomonas sp.
    Isoamylase, Pseudomonas sp. (EC 3.2.1.68) is an enzyme systematically named glycogen 6-α-D-glucan hydrolase. Isoamylase catalyzes the hydrolysis of (1→6)-α-D-glycosidic bonds in glycogen, amylopectin, and their β-limited dextrins. Isoamylase can also effectively hydrolyze amylopectin.
    Isoamylase, Pseudomonas sp.
  • HY-157488
    α-Glucosidase-IN-46
    		Inhibitor
    α-Glucosidase-IN-46 is a potent α-glucosidase inhibitor with an IC50 of 26.0 μM. α-Glucosidase-IN-46 can be used for the research of type 2 diabetes.
    α-Glucosidase-IN-46
  • HY-N7599
    Chrysophanol triglucoside
    		Inhibitor
    Chrysophanol triglucoside is an anthraquinone isolated from Cassia obtusifolia, inhibits protein tyrosine phosphatases 1B (PTP1B) and α-glucosidase with IC50s of 80.17 and 197.06 µM, respectively. Chrysophanol triglucoside has the potential for diabetes research.
    Chrysophanol triglucoside
  • HY-163975
    α-Glucosidase-IN-72
    		Inhibitor
    α-Glucosidase-IN-72 (compound 5i) is a 2,4-dichloro-N-phenylacetamide derivative and an α-glucosidase inhibitor (IC50: 6 μM). α-Glucosidase-IN-72 does not follow Lipinski's "rule of five" and does not induce cancer.
    α-Glucosidase-IN-72
  • HY-W995365
    Nojirimycin
    		Inhibitor
    Nojirimycin is a nitrogen-containing sugar analog and glycosidase inhibitor. Nojirimycin contains a ring nitrogen atom, which acts as an isostere of the ring oxygen atom to inhibit glycosidases. Nojirimycin belongs to a class of nitrogen-containing sugar analogs with a ring nitrogen atom.
    Nojirimycin
  • HY-146128
    Anti-hyperglycemic agent-1
    		Inhibitor
    Anti-hyperglycemic agent-1 (compound 10) is a potent α-Glucosidase inhibitor, with an IC50 of 0.53 μM. Anti-hyperglycemic agent-1 can be used for diabetes research.
    Anti-hyperglycemic agent-1
  • HY-P2769
    Agarase
    Agarase is a glycosidase that catalyzes the hydrolysis of agar into oligosaccharides.
    Agarase
  • HY-N17925
    Falandioside B
    		Inhibitor
    Falandioside B is an α-glucosidase inhibitor with an IC50 of 107.52 μM. Falandioside B scavenges ABTS radical cations. Falandioside B is applicable to research related to postprandial hyperglycemia.
    Falandioside B
  • HY-E71299B
    β-Galactosidase 42A, Thermotoga maritima
    β-Galactosidase 42A, Thermotoga maritima (EC 3.2.1.23) is a hydrolase enzyme that catalyzes the hydrolysis of β-galactosides into monosaccharides. Substrates of different β-galactosidases include ganglioside GM1, lactosylceramides, lactose, and various glycoproteins.
    β-Galactosidase 42A, Thermotoga maritima
  • HY-D3187
    HMRef-αMan
    		Substrate
    HMRef-αMan is a substrate-based green fluorescent probe (Ex/Em=465 nm/515 nm) targeting MAN2C1 (α-mannosidase). HMRef-αMan can be specifically cleaved by MAN2C1 to generate a highly fluorescent product, which thus gets activated to produce green fluorescence in malignant breast tissues, benign lesions and living cancer cells. The signal intensity of HMRef-αMan is directly correlated with MAN2C1 activity, and it can effectively detect tiny breast cancer lesions with a diameter of less than 1 mm. When used in combination with the red-emitting γ-glutamyl transpeptidase (GGT) probe gGlu-2OMe SiR600 (HY-D3188), HMRef-αMan enables precise optical differentiation of breast tissue types via a dual-color imaging strategy. HMRef-αMan has been widely used in the research of breast diseases such as breast cancer, fibroadenoma, phyllodes tumor and various types of papilloma.
    HMRef-αMan
  • HY-147964
    α-Glucosidase-IN-9
    		Inhibitor
    α-Glucosidase-IN-9 (compound 7) is a potent α-glucosidase inhibitor, with an IC50 of 55.6 μM. α-Glucosidase-IN-9 can be used for type II diabetes research.
    α-Glucosidase-IN-9
  • HY-109514
    Imiglucerase
    Imiglucerase is a recombinant human glucocerebrosidase that glucosylceramide to glucose and ceramide. Imiglucerase can be used for the study of type 1 (non-neuronopathic) and type 3 (chronic neuronopathic) Gaucher's disease.
    Imiglucerase
  • HY-176221
    α-Glucosidase-IN-92
    		Inhibitor
    α-Glucosidase-IN-92 (compound 14b) is a non-competitive inhibitor targeting α-glucosidase (IC50=64.0 μM), with better inhibitory potency than Acarbose (HY-B0089) (IC50=750 μM). α-Glucosidase-IN-92 has good oral bioavailability and can cross the blood-brain barrier. α-Glucosidase-IN-92 can delay carbohydrate hydrolysis and reduce postprandial blood glucose. α-Glucosidase-IN-92 can be used in anti-glycemic research for type 2 diabetes.
    α-Glucosidase-IN-92
  • HY-E71297
    β-Galactosidase 2A, Bacteroides thetaiotaomicron
    β-Galactosidase 2A, Bacteroides thetaiotaomicron (EC 3.2.1.23) is a hydrolase enzyme that catalyzes the hydrolysis of β-galactosides into monosaccharides. Substrates of different β-galactosidases include ganglioside GM1, lactosylceramides, lactose, and various glycoproteins.
    β-Galactosidase 2A, Bacteroides thetaiotaomicron
  • HY-E71305
    β-Glucosidase 1A, Bacillus halodurans
    β-Glucosidase 1A, Bacillus halodurans (EC 3.2.1.21) is a glucosidase enzyme that acts upon β1->4 bonds linking two glucose or glucose-substituted molecules (i.e., the disaccharide cellobiose) . β-Glucosidase is one of the cellulases, enzymes involved in the decomposition of cellulose and related polysaccharides; more specifically, an exocellulase with specificity for a variety of beta-D-glycoside substrates. It catalyzes the hydrolysis of terminal non-reducing residues in beta-D-glucosides with release of glucose.
    β-Glucosidase 1A, Bacillus halodurans
  • HY-N18182
    Mudanpioside E
    		Inhibitor
    Mudanpioside E is an orally effective paeoniflorin-type monoterpene glycoside antiallergic agent, with an IC50 of 40.34 μM against IgE-mediated β-hexosaminidase release. Mudanpioside E reverses the inhibitory effect of the modified Xiaoqinglong Decoction extract (paeonia root component removed) on passive cutaneous anaphylaxis in mice. Mudanpioside E itself shows no activity against passive cutaneous anaphylaxis. Mudanpioside E can be used in research related to allergic diseases.
    Mudanpioside E
Cat. No. Product Name / Synonyms Application Reactivity